Goserelin
| Data klinis | |
|---|---|
| Nama dagang | Zoladex, lainnya |
| Nama lain | D-Ser(But)6Azgly10LHRH |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a601002 |
| Kategori kehamilan |
|
| Rute pemberian | Implan |
| Kelas obat | Analog GnRH; Agonis GnRH; Antigonadotropin |
| Kode ATC | |
| Status hukum | |
| Status hukum |
|
| Data farmakokinetika | |
| Pengikatan protein | 27,3% |
| Waktu paruh eliminasi | 4–5 jam |
| Pengenal | |
| |
| Nomor CAS | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.212.024 |
| Data sifat kimia dan fisik | |
| Rumus | C59H84N18O14 |
| Massa molar | 1269.410 g/mol |
| Model 3D (JSmol) | |
| |
| |
| | |
Goserelin (INN, USAN, BAN), atau goserelin asetat, dijual dengan merk dagang Zoladex (oleh AstraZeneca), adalah obat yang digunakan untuk menekan produksi hormon seks (testosterone dan estrogen), khususnya dalam penanganan kanker payudara dan prostat.[1][2]
Goserelin dapat menyebabkan efek samping seperti rasa sakit di tulang, sakit kepala, sakit perut, depresi, kesulitan buang air kecil, berat badan naik, payudara membengkak, kesulitan ereksi, dan berkurangnya nafsu seksual. Pengguna goserelin juga dapat kehilangan ingatan.[3][4]
Penggunaan Zoladex diizinkan di Amerika Serikat pada tahun 1989 untuk menangani kanker prostat.[5]
Referensi
- ^ Dictionary of Organic Compounds. CRC Press. hlm. 3372–. ISBN 978-0-412-54090-5. Diarsipkan dari asli tanggal 2023-08-07. Diakses tanggal 2018-05-18.
- ^ I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. hlm. 136–. ISBN 978-94-011-4439-1. Diarsipkan dari asli tanggal 2023-08-07. Diakses tanggal 2018-05-18.
- ^ Newton CR, Yuzpe AA, Timmon IS, Slota MD. Memory complaints: a side effect of continued exposure to gonadotropin-releasing hormone agonists (GnRHa). Paper presented at: Conjoint Annual Meetings of the American Fertility Society and the Canadian Fertility and Andrology Society; October 11–14, 1993; Montreal, Canada.
- ^ Friedman AJ, Juneau-Norcross M, Rein MS. Adverse effects of leuprolide acetate depot treatment. Fertil Steril. 1993;59(2):448-450.
- ^ "FDA Approval for Zoladex 3.6 mg". Diarsipkan dari asli tanggal 2007-03-04. Diakses tanggal 2018-05-18.
Pranala luar
- One man's experience of prostate cancer treatment using goserelin Diarsipkan 2009-02-01 di Wayback Machine. - BBC News
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.